Monday, November 5, 2018 - RFP release
Tuesday, December 18, 2018 - Deadline for submission of pre-proposals (5 pm ET)
Monday, January 28, 2019 - Announcement of projects selected for full proposals
Friday, March 15, 2019 - Deadline for submission of full proposals (5 pm ET)
Friday, April 12, 2019 - Announcement of new awards for 2019
Monday, July 1, 2019 - Funding start date for new awards
I. Program Eligibility
Applicants Eligible for Funding: Assistant professors, associate professors, and professors who have research programs located in the HMS Quadrangle (including HSCRB faculty who assign intellectual property (IP) to Harvard University and LSP investigators whose IP is governed by joint Harvard–affiliate institutional agreements) are eligible to apply for funding.
Principal investigators (PIs) must be HMS Quad faculty as described above. Collaborations are permitted with both HMS Quad investigators and non-HMS Quad investigators. Interdepartmental and/or inter-institutional collaborations are required for applications for funding from the gift that is pledged specifically to support collaborative research related to Alzheimer’s disease and Parkinson’s disease.
All awards will be managed through HMS.
See also Section IX.2. for requirements related to inventions and intellectual property.
Activities Eligible for Funding: The focus of the proposal should be early-stage therapeutics research that has the potential to lead to commercialization. The committee has a broad view of therapeutics and will consider projects involving, among others, protein therapeutics, small molecules, gene therapy, AAV-vector based therapies, oligonucleotide-based therapeutics, and cell therapies